{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:52:12Z","timestamp":1794081132689,"version":"4.8.0"},"reference-count":22,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The present study seeks to identify the nutritional risk factors involved in the development of neuropathies induced by chemotherapeutic treatments. Unlike the gastrointestinal or hematological adverse effects of chemotherapy there is no protective treatment strategy for polyneuropathy. The aim of this study was to find possible deficiencies in nutritional factors, which can be used for supplementation in the future for prevention of chemotherapy-induced neuropathy development. We analyzed 70 patients undergoing paclitaxel chemotherapy and evaluated the risk factors involved in chemotherapy-induced peripheral neuropathy (CIPN). Several risk factors were considered in the development of CIPN, including deficiency of vitamin B1, B6, and D and fatty acids. The occurrence of CIPN complication in 60% cases was observed. We found significant differences in vitamin D and saturated fatty acid concentration. Vitamin D levels in the group without CIPN were estimated to be 38.2 (24.95, 47.63) nmol\/L, whereas in the group with CIPN it was determined to be 25.6 (19.7, 32.55) nmol\/L, p = 0.008. The level of total saturated fatty acids in the group without CIPN was of 32.613 Area % (31.322; 36.262), whereas in the group with CIPN it was of 34.209 Area % (32.86; 39.386), p = 0.01. The obtained results suggest a diet lower in saturated fatty acid content during chemotherapy. The most significant finding was that supplementation of vitamin D before chemotherapy could be an efficient neuroprotective in CIPN prophylaxis, as significantly lower levels 25OH derivative of vitamin D were observed in the CIPN group throughout the study period.<\/jats:p>","DOI":"10.3390\/nu9060535","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T03:52:54Z","timestamp":1496116374000},"page":"535","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy"],"prefix":"10.3390","volume":"9","author":[{"given":"Jiri","family":"Grim","sequence":"first","affiliation":[{"name":"Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Ticha","sequence":"additional","affiliation":[{"name":"Department of Research and Development, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech"},{"name":"Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radomir","family":"Hyspler","sequence":"additional","affiliation":[{"name":"Department of Research and Development, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech"},{"name":"Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Valis","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Zadak","sequence":"additional","affiliation":[{"name":"Department of Research and Development, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"key":"ref_1","unstructured":"(2017, April 05). Cancernetwork. Available online: http:\/\/www.cancernetwork.com\/oncology-nursing\/chemotherapy-induced-peripheral-neuropathy-cancer-survivors."},{"key":"ref_2","unstructured":"(2017, April 05). Cancer Supportive Survivorship Care. Available online: http:\/\/www.cancersupportivecare.com\/nervepain.html."},{"key":"ref_3","first-page":"261","article-title":"The permeability of capillaries among the small granule-containing cells in rat superior cervical ganglia: And ultrastructural lanthanum tracer study","volume":"6","author":"Chau","year":"1991","journal-title":"Histol. Histopathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410350310","article-title":"Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies","volume":"35","author":"Chaudhry","year":"1994","journal-title":"Ann. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1005805907311","article-title":"Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing","volume":"35","author":"Forsyth","year":"1997","journal-title":"J. Neuro Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1188\/05.CJON.189-193","article-title":"Case report: Painful peripheral neuropathy following treatment with docetaxel for breast cancer","volume":"9","author":"Wampler","year":"2005","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_7","unstructured":"(2017, April 05). Up To Date. Available online: http:\/\/www.uptodate.com\/contents\/image?imageKey=ONC%2F67516&topicKey=ONC%2F2836&source=see_link&utdPopup=true."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/bmj.1.6113.610","article-title":"High incidence of vincristine-induced neuropathy in lymphomas","volume":"11","author":"Watkins","year":"1978","journal-title":"Br. Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/1097-0142(19901015)66:8<1697::AID-CNCR2820660808>3.0.CO;2-G","article-title":"Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin","volume":"66","year":"1990","journal-title":"Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Amptoulach, S., and Tsavaris, N. (2011). Neurotoxicity caused by the treatment with platinum analogues. Chemother. Res. Pract.","DOI":"10.1155\/2011\/843019"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/01.WNL.0000043691.53710.53","article-title":"Toxic neuropathy in patients with pre-existing neuropathy","volume":"60","author":"Chaudhry","year":"2003","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/annonc\/mdh348","article-title":"Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy","volume":"15","author":"Cavaletti","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ghoreishi, Z., Esfahani, A., Djazayeri, A., Djalali, M., Golestan, B., Ayromlou, H., Hashemzade, S., Asghari Jafarabadi, M., Montazeri, V., and Keshavarz, S.A. (2012). Omega-3 fatty acids are protective against paclitaxel-induces peripheral neuropathy: A randomized double-blind placebo controlled trial. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-355"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00520-016-3404-y","article-title":"A randomized, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing development of chemotherapy-induced peripheral neuropathy (CIPN)","volume":"25","author":"Schloss","year":"2017","journal-title":"Support. Care Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1089\/neu.2008.0593","article-title":"Vitamin D2 potentiates axon regeneration","volume":"25","author":"Chabas","year":"2008","journal-title":"J. Neurotrauma"},{"key":"ref_16","first-page":"235","article-title":"Neoadjuvant chemotherapy for breast cancer with weekly nab-paclitaxel by epirubicin and cyclofosfamide-results of a case series","volume":"28","author":"Hahn","year":"2014","journal-title":"In Vivo"},{"key":"ref_17","unstructured":"(2017, April 05). Michigan Neuropathy Screening Instrument. Available online: http:\/\/www.med.umich.edu\/borc\/profs\/documents\/svi\/MNSI_patient.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/1097-0142(19950301)75:5<1141::AID-CNCR2820750514>3.0.CO;2-U","article-title":"Peripheral toxicity of taxol in patients previously treated with cisplatin","volume":"75","author":"Cavaletti","year":"1995","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/2347-5625.170977","article-title":"New insights into potential prevention and management options for chemotherapy-induced peripheral neuropathy","volume":"3","author":"Schloss","year":"2016","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_20","first-page":"1","article-title":"Clinical toxicities encountered with paclitaxel (TAXOL)","volume":"4","author":"Rowinsky","year":"1993","journal-title":"Semin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/jbmr.387","article-title":"Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship","volume":"26","author":"Powe","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Watson, R.R., and De Meester, F. (2014). Omega-3 Fatty Acids in Brain and Neurological Health, Elsevier. [1st ed.].","DOI":"10.1007\/978-1-62703-215-5"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/6\/535\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:36:49Z","timestamp":1760207809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/6\/535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["nu9060535"],"URL":"https:\/\/doi.org\/10.3390\/nu9060535","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,25]]}}}